BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25670009)

  • 1. Price elasticities in the German Statutory Health Insurance market before and after the health care reform of 2009.
    Pendzialek JB; Danner M; Simic D; Stock S
    Health Policy; 2015 May; 119(5):654-63. PubMed ID: 25670009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consumer price sensitivity in Dutch health insurance.
    van Dijk M; Pomp M; Douven R; Laske-Aldershof T; Schut E; de Boer W; de Boo A
    Int J Health Care Finance Econ; 2008 Dec; 8(4):225-44. PubMed ID: 18709549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Market Concentration in the Statutory Health Insurance of Germany since the Introduction of Free Choice of Sickness Funds].
    Götze R
    Gesundheitswesen; 2016 Nov; 78(11):715-720. PubMed ID: 25760099
    [No Abstract]   [Full Text] [Related]  

  • 4. Consumer price sensitivity and social health insurer choice in Germany and The Netherlands.
    Schut FT; Gress S; Wasem J
    Int J Health Care Finance Econ; 2003 Jun; 3(2):117-38. PubMed ID: 14626009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands.
    Douven R; Katona K; T Schut F; Shestalova V
    Eur J Health Econ; 2017 Nov; 18(8):1047-1064. PubMed ID: 28243775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The German Central Health Fund-recent developments in health care financing in Germany.
    Göpffarth D; Henke KD
    Health Policy; 2013 Mar; 109(3):246-52. PubMed ID: 23200602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managed competition and consumer price sensitivity in social health insurance.
    Schut FT; Hassink WH
    J Health Econ; 2002 Nov; 21(6):1009-29. PubMed ID: 12475123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free choice of sickness funds: economic implications and ethical aspects of the 1992 health care reform in Germany.
    Cassel D; Boroch W
    J Med Philos; 1995 Dec; 20(6):657-67. PubMed ID: 8861572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Competition among health insurance funds: the position of the PKV].
    Leienbach V
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(10):639-42; discussion 643. PubMed ID: 20120193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in price elasticities of demand for health insurance: a systematic review.
    Pendzialek JB; Simic D; Stock S
    Eur J Health Econ; 2016 Jan; 17(1):5-21. PubMed ID: 25398619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care reform: managed competition and beyond.
    Custer W
    EBRI Issue Brief; 1993 Mar; (135):1-33. PubMed ID: 10129612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. German risk structure compensation: enhancing equity and effectiveness.
    Files A; Murray M
    Inquiry; 1995; 32(3):300-9. PubMed ID: 7591043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing health care market reform through an insurance exchange: essential policy components, the public plan option, and other issues to consider.
    Fronstin P; Ross MN
    EBRI Issue Brief; 2009 Jun; (330):1-22. PubMed ID: 19545086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition.
    Busse R; Blümel M; Knieps F; Bärnighausen T
    Lancet; 2017 Aug; 390(10097):882-897. PubMed ID: 28684025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural changes in the German pharmaceutical market: price setting mechanisms based on the early benefit evaluation.
    Henschke C; Sundmacher L; Busse R
    Health Policy; 2013 Mar; 109(3):263-9. PubMed ID: 23339876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the sickness funds in the Belgian health care market.
    Nonneman W; van Doorslaer E
    Soc Sci Med; 1994 Nov; 39(10):1483-95. PubMed ID: 7863360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Market competition in health care markets in the Netherlands: some lessons for England?
    den Exter AP; Guy MJ
    Med Law Rev; 2014; 22(2):255-73. PubMed ID: 24841530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elasticities of market shares and social health insurance choice in Germany: a dynamic panel data approach.
    Tamm M; Tauchmann H; Wasem J; Gress S
    Health Econ; 2007 Mar; 16(3):243-56. PubMed ID: 16981190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forming and reforming the market for third-party purchasing of health care: a German perspective.
    Graf von der Schulenburg JM
    Soc Sci Med; 1994 Nov; 39(10):1473-81. PubMed ID: 7863359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [External and internal financing in health care].
    Henke KD
    Med Klin (Munich); 2007 May; 102(5):366-72. PubMed ID: 17497087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.